Panichaporn Saranya, Chanapai Wanwisa, Srisomnuek Ananya, Thaweeratthakul Phakhamon, Katchamart Wanruchada
Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Division of Clinical Trials, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Patient Prefer Adherence. 2022 Aug 17;16:2149-2158. doi: 10.2147/PPA.S374445. eCollection 2022.
To evaluate the psychometric properties and feasibility of the Thai version of Compliance-Questionnaire-Rheumatology (CQR)-19.
A cross-sectional study was conducted in the Rheumatology clinic of Siriraj hospital from October 2020 to March 2022. Literate patients diagnosed with rheumatoid arthritis and aged ≥ 18 years old were included. Participants completed the Thai CQR-19 at baseline and during a follow-up visit. A pill count at the follow-up visit indicating that ≤ 80% of prescribed pills were taken was defined as poor compliance. Feasibility was assessed by the time to completion and the number of missing questions.
156 participants were enrolled and 88% were in good compliance. The sensitivity of the CQR-19 to detect good compliance was 78.2% and the specificity was 27.8%. The Thai CQR-19 showed moderate agreement (Gwet's AC1= 0.61, p < 0.01) with 72.2% agreement against pill counts. The Thai CQR-19 had good internal consistency (Cronbach's alpha = 0.83) with moderate test-retest reliability (intraclass coefficients = 0.64, 95% CI 0.54-0.73; p < 0.05). There was a weak correlation between the Thai CQR-19 and disease activity ( = 0.20, p < 0.05), and no correlation with functional disability ( = 0.09, p = 0.25). The median (IQR) completion time was 4.42 (3.25-6.16) minutes and 114 (73%) completed all 19 questions.
The Thai version of CQR-19 is a valid and reliable tool to assess medication compliance in Thai patients with RA. To ensure completeness and accuracy, this questionnaire may be administered by interview.
评估泰语版《风湿病合规调查问卷》(CQR)-19的心理测量特性和可行性。
于2020年10月至2022年3月在诗里拉吉医院的风湿病诊所进行了一项横断面研究。纳入了识字的、诊断为类风湿关节炎且年龄≥18岁的患者。参与者在基线时和随访期间完成泰语版CQR-19。随访时的药丸计数显示服用的处方药丸≤80%被定义为依从性差。通过完成时间和缺失问题数量评估可行性。
共纳入156名参与者,88%依从性良好。CQR-19检测良好依从性的敏感性为78.2%,特异性为27.8%。泰语版CQR-19显示出中度一致性(Gwet's AC1 = 0.61,p < 0.01),与药丸计数的一致性为72.2%。泰语版CQR-19具有良好的内部一致性(Cronbach's alpha = 0.83),重测信度中等(组内相关系数 = 0.64,95%CI 0.54 - 0.73;p < 0.05)。泰语版CQR-19与疾病活动之间存在弱相关性( = 0.20, p < 0.05),与功能残疾无相关性( = 0.09, p = 0.25)。完成时间的中位数(IQR)为4.42(3.25 - 6.16)分钟,114名(73%)完成了所有19个问题。
泰语版CQR-19是评估泰国类风湿关节炎患者药物依从性的有效且可靠的工具。为确保完整性和准确性,该问卷可通过访谈进行。